Growth Metrics

Pfizer (PFE) Asset Utilization Ratio (2016 - 2025)

Pfizer (PFE) has disclosed Asset Utilization Ratio for 17 consecutive years, with 0.23 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 75.05% to 0.23 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.23 through Dec 2025, up 75.05% year-over-year, with the annual reading at 0.3 for FY2025, 666.08% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.23 at Pfizer, up from 0.15 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.67 in Q4 2022, with the low at 0.11 in Q4 2023.
  • Average Asset Utilization Ratio over 5 years is 0.28, with a median of 0.21 recorded in 2021.
  • The sharpest move saw Asset Utilization Ratio skyrocketed 95.99% in 2021, then plummeted 83.7% in 2023.
  • Over 5 years, Asset Utilization Ratio stood at 0.53 in 2021, then grew by 24.52% to 0.67 in 2022, then tumbled by 83.63% to 0.11 in 2023, then rose by 21.35% to 0.13 in 2024, then skyrocketed by 75.05% to 0.23 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.23, 0.15, and 0.14 for Q4 2025, Q3 2025, and Q2 2025 respectively.